Pierluigi Ciet

Dr. Pierluigi Ciet


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
FPFederica Pederiva
Federica Pederiva
SRSteven S. Rothenberg
Steven S. Rothenberg
NHNigel Hall
Nigel Hall
HIHanneke Ijsselstijn
Hanneke Ijsselstijn
KWKenneth K. Y. Wong
Kenneth K. Y. Wong
JSJohannes Marco Schnater
Johannes Marco Schnater

1 June 2014 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
WKWieying Kuo
Wieying Kuo
Pierluigi CietPierluigi Ciet
Pierluigi Ciet
HTHarm A. W. M. Tiddens
Harm A. W. M. Tiddens
WZWei Zhang
Wei Zhang
RGR. Paul Guillerman
R. Paul Guillerman
MSMarcel van Straten
Marcel van Straten
Computed tomography (CT) is a sensitive technique to monitor structural changes related to cystic fibrosis (CF) lung disease. It detects structural pulmonary abnormalities such as bronchiectasis and trapped air, at an early stage, before they become apparent with other diagnostic tests. Clinical decisions may be influenced by knowledge of these abnormalities. CT imaging, however, comes with risk related to ionizing radiation exposure. The aim of this review is to discuss the risk of routine CT imaging in patients with CF, using current models of radiation-induced cancer, and to put this risk in perspective with other medical and nonmedical risks. The magnitude of the risk is a complex, controversial matter. Risk analyses have largely been based on a linear no-threshold model, and excess relative and excess absolute risk estimates have been derived mainly from atomic bomb survivors. The estimates have large confidence intervals. Our risk estimates are in concordance with previously reported estimates. A large proportion of radiation to which humans are exposed is from natural background sources and varies widely depending on geographical location. The risk differences due to variation in background radiation can be larger than the risks associated with CF lung disease monitoring by CT. We conclude that the risk related to routine usage of CT in clinical care is small. In addition, a life-limiting disease, such as CF, lowers the risk of radiation-induced cancer. Nonetheless, the use of CT should always be justified and the radiation dose should be kept as low as reasonably achievable.

5 September 2015 in Pediatric Radiology
Verified
Journal Article
Open access
PDF file
Pierluigi CietPierluigi Ciet
Pierluigi Ciet
HTHarm A. W. M. Tiddens
Harm A. W. M. Tiddens
PWPiotr A. Wielopolski
Piotr A. Wielopolski
JWJim M. Wild
Jim M. Wild
ELEdward Y. Lee
Edward Y. Lee
MLMaarten Lequin
Maarten Lequin
Pediatric chest MRI is challenging. High-resolution scans of the lungs and airways are compromised by long imaging times, low lung proton density and motion. Low signal is a problem of normal lung. Lung abnormalities commonly cause increased signal intenstities. Among the most important factors for a successful MRI is patient cooperation, so the long acquisition times make patient preparation crucial. Children usually have problems with long breath-holds and with the concept of quiet breathing. Young children are even more challenging because of higher cardiac and respiratory rates giving motion blurring. For these reasons, CT has often been preferred over MRI for chest pediatric imaging. Despite its drawbacks, MRI also has advantages over CT, which justifies its further development and clinical use. The most important advantage is the absence of ionizing radiation, which allows frequent scanning for short- and long-term follow-up studies of chronic diseases. Moreover, MRI allows assessment of functional aspects of the chest, such as lung perfusion and ventilation, or airways and diaphragm mechanics. In this review, we describe the most common MRI acquisition techniques on the verge of clinical translation, their problems and the possible solutions to make chest MRI feasible in children.

30 May 2015 in European Radiology
Verified
Journal Article
Closed access
PDF file
Pierluigi CietPierluigi Ciet
Pierluigi Ciet
GSGoffredo Serra
Goffredo Serra
SBSilvia Bertolo
Silvia Bertolo
SSSandra Spronk
Sandra Spronk
MRMirco Ros
Mirco Ros
GMGiovanni Morana
Giovanni Morana

5 May 2016 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
EMEsther van Mastrigt
Esther van Mastrigt
KLKarla Logie
Karla Logie
Pierluigi CietPierluigi Ciet
Pierluigi Ciet
IRIrwin K.M. Reiss
Irwin K.M. Reiss
LDLiesbeth Duijts
Liesbeth Duijts
HTHarm A.W.M. Tiddens
Harm A.W.M. Tiddens

6 May 2015 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
SWStephan Ca Wens
Stephan Ca Wens
Pierluigi CietPierluigi Ciet
Pierluigi Ciet
APAdria Perez-Rovira
Adria Perez-Rovira
KLKarla Logie
Karla Logie
ESElizabeth Salamon
Elizabeth Salamon
APAns T van der Ploeg
Ans T van der Ploeg
Pompe disease is a progressive metabolic myopathy. Involvement of respiratory muscles leads to progressive pulmonary dysfunction, particularly in supine position. Diaphragmatic weakness is considered to be the most important component. Standard spirometry is to some extent indicative but provides too little insight into diaphragmatic dynamics. We used lung MRI to study diaphragmatic and chest-wall movements in Pompe disease. In ten adult Pompe patients and six volunteers, we acquired two static spirometer-controlled MRI scans during maximum inspiration and expiration. Images were manually segmented. After normalization for lung size, changes in lung dimensions between inspiration and expiration were used for analysis; normalization was based on the cranial-caudal length ratio (representing vertical diaphragmatic displacement), and the anterior-posterior and left-right length ratios (representing chest-wall movements due to thoracic muscles). We observed striking dysfunction of the diaphragm in Pompe patients; in some patients the diaphragm did not show any displacement. Patients had smaller cranial-caudal length ratios than volunteers (p < 0.001), indicating diaphragmatic weakness. This variable strongly correlated with forced vital capacity in supine position (r = 0.88) and postural drop (r = 0.89). While anterior-posterior length ratios also differed between patients and volunteers (p = 0.04), left-right length ratios did not (p = 0.1). MRI is an innovative tool to visualize diaphragmatic dynamics in Pompe patients and to study chest-walland diaphragmatic movements in more detail. Our data indicate that diaphragmatic displacement may be severely disturbed in patients with Pompe disease.